UNM Shorts Hold Near Record Highs as Q3 Earnings Land

Unum Group, the Tennessee-based group disability and life insurer, reports Q3 results this morning with short interest parked near its highest level in over a year.

Short positions stand at around 5.2 million shares, 3.1% of the free float, essentially unchanged from the record reached last week when the previous preview noted a 24% monthly increase. The pace of accumulation has since slowed, with short interest actually edging back a touch on November 2, but the absolute level remains elevated. Crucially, that position is not under any pressure from the lending market. Availability is extremely loose, with roughly 120 million shares available to borrow against short interest of just over 5 million. The cost to borrow has fallen more than 50% over the past week to around 0.26%, the lowest reading in the recent history shown. Shorts who built positions into the print did so in a frictionless environment, with no squeeze mechanics in play.

Options positioning tells a subtly more cautious story than the headline numbers suggest. The put/call ratio has nudged to 0.07, almost two standard deviations above its 20-day average, though the absolute level remains very low by any broader market standard. UNM options are overwhelmingly call-heavy, so even this relative elevation is a mild shift rather than a bearish signal. The stock itself is up around 2% on the week, tracking roughly in line with peers: MET added 0.9%, LNC gained 3.6%, and CNO jumped nearly 8%, meaning UNM has held its ground without matching the sector's stronger names.

The debate heading into the print splits cleanly on benefit ratios. The bull case rests on Unum's group benefits franchise generating over 20% return on equity with more than 90% free cash flow conversion, helped by higher rates and steady premium growth. The bear case centres on group disability benefit ratios running above 60%, which has already weighed on EPS estimates, alongside rising long-term care incidence rates. Analyst targets cluster in a range from Morgan Stanley's equal-weight at $92 to Barclays' overweight at $109, with Wells Fargo raising its target to $102 in October. The mean target of around $102 implies modest upside from the $91 close, but the Street is not uniformly positive: JPMorgan sits at neutral with a $98 target. BlackRock lifted its stake above 10% of shares in a April 13D/G filing, and FMR added materially through the summer, while Norges Bank trimmed. Stakes are as last disclosed around the 5% threshold.

The Q3 print is therefore less a question of whether Unum's core franchise is intact and more a test of whether disability claims trends have stabilised enough to put the benefit ratio concern to rest.